Navigation Links
CVBT Interim Board of Directors Remains In Place
Date:6/20/2013

LAS VEGAS, June 21, 2013 /PRNewswire/ -- CardioVascular BioTherapeutics, Inc. (CVBT) announced today that the Delaware Court of Chancery ruled that Mickael A. Flaa, Grant Gordon, Calvin A. Wallen III, Jon Ross, and Robert Schleizer will remain in place as the CVBT Board of Directors pending resolution of the lawsuit filed on June 9, 2013, by Mickael A. Flaa in that Court.  The Delaware lawsuit seeks, among other things, to confirm the validity of the action by written consent of stockholders on June 7, 2013, to remove Daniel C. Montano, John (Jack) Jacobs, Ernest C. Montano, Viktoriya T. Montano, Ernest Montano III, and Joong Ki Baik as directors of CVBT.  Pending resolution of the Delaware lawsuit, or further order of the Delaware Court of Chancery, the power of CVBT's interim Board of Directors to take certain [extraordinary] actions on behalf of CVBT will be limited by a status quo order, which has not yet been entered.

About CardioVascular BioTherapeutics
CVBT is a biopharmaceutical company developing drug candidates with FGF-1 as its active pharmaceutical ingredient (API) for diseases characterized by inadequate blood flow to tissue or organs. The company is the sponsor of a Phase II trial to treat severe coronary heart disease (CVBT-141H), and has received FDA authorization for a Phase I trial to treat peripheral arterial disease (CVBT-141C). A Late-Stage trial to treat chronic diabetic foot ulcers (CVBT-141B) is planned pending FDA approval.

Forward
'/>"/>

SOURCE CardioVascular BioTherapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. GW Pharmaceuticals to Report Interim 2013 Results and Host Conference Call on 3 June, 2013
2. New Interim Analysis From Observational Study Suggests That Delivery Of Insulin Via Valeritas V-Go Shows Promise In Improving Glycemic Control For Patients With Type 2 Diabetes
3. Immunomic Therapeutics Announces Interim Data Analysis of Phase I Study to Treat Japanese Red Cedar Allergy
4. Relievant Medsystems Achieves Completion of Interim Safety Data Analysis of Intracept in SMART Pivotal Study and Expands Senior Leadership Team
5. Inovio Collaborator ChronTech Reports Interim Phase II Clinical Study Results from ChronVac-C Vaccine for Hepatitis C Infection
6. Convergence Pharmaceuticals Announces Successful Interim Data from Ground-Breaking Phase II Trigeminal Neuralgia Study
7. OncoSec Medical Updates Analysis of Interim Data for Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
8. Boehringer Ingelheim Announces Interim Results Evaluating Virologic Response Rates in HCV/HIV Co-Infected Patients Treated with Faldaprevir
9. Avanir Pharmaceuticals Announces Positive Interim Data From Pharmacokinetic Study With Next Generation Compound AVP-786
10. Vermillion Appoints Bruce A. Huebner as Interim Chief Executive Officer
11. Golden Meditech Announces 2012 / 2013 Interim Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... NEW YORK and LONDON ... distributor of market intelligence, MarketResearch.com is pleased to announce ... Research and Consultancy focusing on the active pharmaceutical ingredient ... Research visit: http://www.marketresearch.com/land/publisher.asp?vendorid=4023&progid=86891 . In ... Market – Forecast to 2020 , ...
(Date:11/26/2014)... , Nov. 25, 2014  goBalto, Inc., the ... been recognized as a winner of Red Herring,s ... Global Top 100 North America award in 2013, marking ... technology landscape. Red Herring,s Top 100 Global ... promising new companies and entrepreneurs. Red Herring editors were ...
(Date:11/26/2014)... , Nov. 25, 2014 Nanomix ... on the development of mobile diagnostic tests ... in hospital and pre-hospital settings, today announced ... 13485:2003 certification.  The certification was awarded by ... the world,s leading certification bodies. ...
Breaking Medicine Technology:MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3goBalto Selected as a 2014 Red Herring Top 100 Global Company 2goBalto Selected as a 2014 Red Herring Top 100 Global Company 3Nanomix Receives ISO 13485:2003 Certification 2
... DIEGO, Oct. 26 The ... Circle at their Annual Scientific Meeting, becoming the first medical association ... collaborative community. Meeting attendees, authors and presenters can, for the ... latest breakthroughs in clinical gastroenterology during -- and well after -- ...
... 26 Sequenom, Inc. (Nasdaq: SQNM ), today ... the company,s interim chief financial officer effective November 10, ... officer and chairman of the board, Harry F. Hixson, ... Prior to the effective date of Mr. Maier,s appointment ...
Cached Medicine Technology:American College of Gastroenterology to Revolutionize Scientific Exchange on Within3 2American College of Gastroenterology to Revolutionize Scientific Exchange on Within3 3Sequenom Announces Paul Maier to Become Interim Chief Financial Officer 2Sequenom Announces Paul Maier to Become Interim Chief Financial Officer 3
(Date:11/27/2014)... Cambrionix Ltd today announced that it ranked number 10 in ... 50 fastest-growing technology companies in the UK. Rankings are ... Cambrionix Ltd grew 2989 percent during this period. ... Cambridgeshire and East and first in the sector of Electronics. ... of the hard work put in by our team who ...
(Date:11/27/2014)... 27, 2014 Blood-borne pathogens raise the ... precautions and procedures in place to counter this. However, ... of things tainted with menstrual blood are taken as ... simpler, more sanitary way to handle tampons and menstrual ... from Sonora, Calif. , He then created a prototype ...
(Date:11/27/2014)... PA (PRWEB) November 27, 2014 "As ... the embarrassing side effects of urinary incontinence," said an ... it and developed this specialized accessory to prevent leakage ... the Incontinence to absorb urine leakage. This prevents stains ... from potential embarrassment. The pad ensures that the individual ...
(Date:11/27/2014)... By Randy Dotinga ... -- Some people,s brains seem pre-wired to acquire a second ... beyond their mother tongue will likely gain a brain boost, ... connected and integrated after learning," said study co-author Ping Li, ... Pennsylvania State University. But it,s even more interesting, Li said, ...
(Date:11/27/2014)... HealthDay Reporter WEDNESDAY, Nov. ... to be safe and produces an immune system response that ... clinical trial results reported by the U.S. National Institutes of ... for the vaccine paves the way for field-testing it in ... as early as January, said Dr. Anthony Fauci, director of ...
Breaking Medicine News(10 mins):Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 2Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 3Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 4Health News:Some People May Be Pre-Wired to Be Bilingual 2Health News:Some People May Be Pre-Wired to Be Bilingual 3Health News:Early Trial Promising for Ebola Vaccine 2Health News:Early Trial Promising for Ebola Vaccine 3
... of prostate cancer is common among older men. Being the ... it is the second leading cause of cancer deaths in ... been a increase in number of detected cases. Most men ... and a prostate-specific antigen (PSA) blood test. In rectal exam ...
... found that women with breast cancer are more likely ... blood. A residue of the fungicide hexachlorobenzene (HCB) were ... that DDT or HCB actually cause breast cancer. The ... for mosquito control in developing countries. DDT, HCB and ...
... a study drinking tea on regular basis help protect ... an increased rate of survival following a heart attack.,Researchers ... group of antioxidants known as,flavonoids, which are plentiful in ... in certain fruits and vegetables, including apples, onions, and ...
... found that evening administration of the central alpha(2)-agonists ... in the morning in hypertensive patients. The study ... to receive once-daily evening administration of guanabenz or ... effects of the two drugs in the morning ...
... Researchers at an American university have found that ... chemical. When one chew broccoli, its cells rupture ... sulphoraphanes. To simulate chewing the researchers crushed raw ... Researchers said that broccoli obtained from common supermarket ...
... question of whether daily moderate exercise could actually prevent ... like jogging, hiking, climbing stairs, racket sports and swimming ... from heart disease. Recommendations in the United States and ... walking, is sufficient for good heart health.// A World ...
Cached Medicine News:
... use. Kit comprises: 1 Miller 0 Premature; 1 Miller ... Ad.; 1 Mac 2 Child; 1 Mac 3 Medium ... Standard, 1 Nylon Carrying Case. The Lite Blade Kit ... take your disposable laryngoscopes anywhere. Each blade and handle ...
... The Flipper® is a unique fiberoptic ... bit of anterior exposure sometimes needed during ... the end of the blade to be ... the handle. This one-handed operation produces a ...
... fiberoptic Naso-Pharyngo-Laryngoscope provides a new standard in ... latest in Fujinon engineering combines high resolution ... a wide 90 degree field of view ... diameter. In addition, the FR-120F offers ...
... CCR Medical's Articulating Tip Laryngoscopes ... in the Industry. The articulating ... by providing an improved view ... and Fiber Optic styles. We ...
Medicine Products: